, Volume 186, Issue 4, pp 517–524 | Cite as

Increases in amphetamine-like discriminative stimulus effects of the abused inhalant toluene in mice

  • Scott E. BowenEmail author
Original Investigation



Toluene, an abused solvent, shares behavioral and pharmacological effects with abused depressant drugs. These effects include ethanol- and pentobarbital-like discriminative stimulus effects. There is also emerging evidence that this abused inhalant may share stimulus effects with abused central nervous system (CNS) stimulants.


To further explore the discriminative stimulus effects of one abused inhalant, this experiment evaluated the amphetamine-like discriminative stimulus effects of toluene.

Materials and methods

Mice were trained to discriminate between d-amphetamine (1.0 mg/kg) and saline in a two-lever drug discrimination procedure in which responding was under the control of a fixed-ratio 15 schedule. Mice were tested after 10-min inhalation exposures to air or toluene (500–6,000 ppm) and stimulus generalization was examined at 0, 15, 30, 45, 60, and 75 min post-exposure.


Concentration-related increases in amphetamine-lever responding were observed for amphetamine doses >0.56 mg/kg with full substitution occurring immediately after testing for 1.0 and 1.78 mg/kg. Partial amphetamine-lever responding was observed for all concentrations of toluene across the 75-min post-exposure test trials. Response rates that had decreased immediately after all toluene exposures recovered within 15-min post exposure.


This partial substitution of toluene for amphetamine suggests that studies of the effects of abused solvents on brain dopaminergic systems need to be included in the study of possible CNS mechanisms.


Amphetamine Toluene Inhalants Mice 



The author wishes to thank Evelena Muhammad for her technical assistance and Drs. John H. Hannigan and Ty Partridge who provided helpful comments on this manuscript.


  1. Anderson CE, Loomis GA (2003) Recognition and prevention of inhalant abuse. Am Fam Physician 68:869–874, 876PubMedGoogle Scholar
  2. Bale AS, Smothers CT, Woodward JJ (2002) Inhibition of neuronal nicotinic acetylcholine receptors by the abused solvent, toluene. Br J Pharmacol 137:375–383CrossRefPubMedGoogle Scholar
  3. Balster RL (1990) Perception of drug effects. In: Berkley MA, Stebbins WC (eds) Comparative perception. Wiley, New York, pp 127–154Google Scholar
  4. Balster RL, Moser VC (1987) Pentobarbital discrimination in the mouse. Alcohol Drug Res 7:233–242PubMedGoogle Scholar
  5. Balster RL, Grech DM, Bobelis DJ (1992) Drug discrimination analysis of ethanol as an N-methyl-d-aspartate receptor antagonist. Eur J Pharmacol 222:39–42CrossRefPubMedGoogle Scholar
  6. Beckstead MJ, Weiner JL, Eger EI, Gong DH, Mihic SJ (2000) Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol 57:1199–205PubMedGoogle Scholar
  7. Beyer CE, Stafford D, LeSage MG, Glowa JR, Steketee JD (2001) Repeated exposure to inhaled toluene induces behavioral and neurochemical cross-sensitization to cocaine in rats. Psychopharmacol 154:198–204CrossRefPubMedGoogle Scholar
  8. Blokhina EA, Dravolina OA, Bespalov AY, Balster RL, Zvartau EE (2004) Intravenous self-administration of abused solvents and anesthetics in mice. Eur J Pharmacol 485:211–218CrossRefPubMedGoogle Scholar
  9. Bowen SE, Balster RL (1996) Effects of inhaled 1,1,1-trichloroethane on locomotor activity in mice. Neurotoxicol Teratol 18:77–81CrossRefPubMedGoogle Scholar
  10. Bowen SE, Balster RL (1997) Desflurane, enflurane, isoflurane and ether produce ethanol-like discriminative stimulus effects in mice. Pharmacol Biochem Behav 57:191–198CrossRefPubMedGoogle Scholar
  11. Bowen SE, Balster RL (1998a) A direct comparison of inhalant effects on locomotor activity and schedule-controlled behavior in mice. Exp Clin Psychopharmacol 6:235–247CrossRefPubMedGoogle Scholar
  12. Bowen SE, Balster RL (1998b) The effects of inhaled isoparaffins on locomotor activity and operant performance in mice. Pharmacol Biochem Behav 61: 271–80CrossRefPubMedGoogle Scholar
  13. Bowen SE, Wiley JL, Balster RL (1996) The effects of abused inhalants on mouse behavior in an elevated plus-maze. Eur J Pharmacol 312:131–136CrossRefPubMedGoogle Scholar
  14. Bowen SE, Daniel J, Balster RL (1999a) Deaths associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend 53:239–245CrossRefPubMedGoogle Scholar
  15. Bowen SE, Wiley JL, Jones HE, Balster RL (1999b) Phencyclidine- and diazepam-like discriminative stimulus effects of inhalants in mice. Exp Clin Psychopharmacol 7:28–37CrossRefPubMedGoogle Scholar
  16. Bowen SE, Batis JC, Mohammadi M, Hannigan JH (2005) Abuse patterns of gestational toluene exposure and early postnatal development in rats. Neurotoxicol Teratol 27:105–116CrossRefPubMedGoogle Scholar
  17. Carboni E, Imperato A, Perezzani L, Di C (1989) Amphetamine, cocaine, phencyclidine, and nomifensine increase extracellular DA concentrations preferentially in nucleus accumbens of freely moving rats. Neuroscience 28:653–661CrossRefPubMedGoogle Scholar
  18. Colotla VA, Bautista S, Lorenzana-Jimenez M, Rodriguez R (1979) Effects of solvents on schedule-controlled behavior. Neurobehav Toxicol 1(Suppl 1):113–118PubMedGoogle Scholar
  19. Cruz SL, Mirshahi T, Thomas B, Balster RL, Woodward JJ (1998) Effects of the abused solvent toluene on recombinant N-methyl-d-aspartate and non-N-methyl-d-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 286:334–340PubMedGoogle Scholar
  20. Drevets WC, Price JC, Kupfer DJ, Kinahan P, Lopresti B, Holt D, Mathis C (1999) PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Neuropyschopharmacology 21:694–709CrossRefGoogle Scholar
  21. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, Price JL, Mathis CA (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatr 49:81–96CrossRefPubMedGoogle Scholar
  22. Evans EB, Balster RL (1991) CNS depressant effects of volatile organic solvents. Neurosci Biobehav Rev 15:233–241CrossRefPubMedGoogle Scholar
  23. Geller I, Hartmann RJ, Randle SR, Gause EM (1979) Effects of acetone and toluene vapors on multiple schedule performance of rats. Pharmacol Biochem Behav 11:395–399CrossRefPubMedGoogle Scholar
  24. Gerasimov MR, Schiffer WK, Marstellar D, Ferrieri R, Alexoff D, Dewey SL (2002) Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend 65:243–251CrossRefPubMedGoogle Scholar
  25. Glowa JR (1981) Some effects of sub-acute exposure to toluene on schedule-controlled behavior. Neurobehav Toxicol Teratol 3:463–465PubMedGoogle Scholar
  26. Glowa JR (1985) Behavioral effects of volatile organic solvents. In Seiden LS, Balster RL (eds) Behavioral pharmacology: the current status. Alan R. Liss, New York, pp 537–552Google Scholar
  27. Glowa JR (1993) Behavioral and neuroendocrine effects of diethyl ether exposure in the mouse. Neurotoxicol Teratol 15:215–221CrossRefPubMedGoogle Scholar
  28. Grant KA (1994) Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. Behav Pharmacol 5:383–404PubMedCrossRefGoogle Scholar
  29. Grant KA, Colombo G (1992) Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-d-aspartate antagonists. J Pharmacol Exp Ther 264:1241–1247Google Scholar
  30. Hinman DJ (1987) Biphasic dose-response relationship for effects of toluene inhalation on locomotor activity. Pharmacol Biochem Behav 26:65–69, JanCrossRefPubMedGoogle Scholar
  31. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE (2004) Overall teen drug use continues gradual decline; but use of inhalants rises. University of Michigan News and Information Services, Ann Arbor, MIGoogle Scholar
  32. Kjellstrand P, Holmquist B, Jonsson I, Romare S, Mansson L (1985) Effects of organic solvents on motor activity in mice. Toxicology 35:35–46CrossRefPubMedGoogle Scholar
  33. Moser VC, Balster RL (1981) The effects of acute and repeated toluene exposure on operant behavior in mice. Neurobehav Toxicol Teratol 3:471–475PubMedGoogle Scholar
  34. Moser VC, Balster RL (1985a) Acute motor and lethal effects of inhaled toluene, 1,1,1- trichloroethane, halothane, and ethanol in mice: effects of exposure duration. Toxicol Appl Pharmacol 77:285–291CrossRefPubMedGoogle Scholar
  35. Moser VC, Balster RL (1985b) Effects of toluene, halothane and ethanol vapor on fixed-ratio performance in mice. Pharmacol Biochem Behav 22:797–802CrossRefPubMedGoogle Scholar
  36. Moser VC, Balster RL (1986) The effects of inhaled toluene, halothane, 1,1,1-trichloroethane, and ethanol on fixed-interval responding in mice. Neurobehav Toxicol Teratol 8:525–31PubMedGoogle Scholar
  37. Ramon MF, Ballesteros S, Martinez-Arrieta R, Torrecilla JM, Cabrera J (2003) Volatile substance and other drug abuse inhalation in Spain. J Toxicol Clin Toxicol 41:931–936CrossRefPubMedGoogle Scholar
  38. Rees DC, Coggeshall E, Balster RL (1985) Inhaled toluene produces pentobarbital-like discriminative stimulus effects in mice. Life Sci 37:1319–1325CrossRefPubMedGoogle Scholar
  39. Rees DC, Knisely JS, Balster RL, Jordan S, Breen TJ (1987a) Pentobarbital-like discriminative stimulus properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice. J Pharmacol Exp Ther 241:507–515PubMedGoogle Scholar
  40. Rees DC, Knisely JS, Breen TJ, Balster RL (1987b) Toluene, halothane, 1,1,1-trichloroethane and oxazepam produce ethanol- like discriminative stimulus effects in mice. J Pharmacol Exp Ther 243:931–937PubMedGoogle Scholar
  41. Riegel AC, French ED (2002) Abused inhalants and central reward pathways: electrophysiological and behavioral studies in the rat. Ann N Y Acad Sci 965:281–291PubMedCrossRefGoogle Scholar
  42. Riegel AC, Ali SF, Torinese S, French ED (2004) Repeated exposure to the abused inhalant toluene alters levels of neurotransmitters and generates peroxynitrite in nigrostriatal and mesolimbic nuclei in rat. Ann N Y Acad Sci 1025:543–551CrossRefPubMedGoogle Scholar
  43. Sanger DJ (1993) Substitution by NMDA antagonists and other drugs in rats trained to discriminate ethanol. Behav Pharmacol 4:523–528PubMedCrossRefGoogle Scholar
  44. Shelton KL, Balster RL (1994) Ethanol drug discrimination in rats: substitution with GABA agonists and NMDA antagonists. Behav Pharmacol 5:441–450PubMedGoogle Scholar
  45. Snoddy AM, Tessel RE (1983) Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol Biochem Behav 19:205–210CrossRefPubMedGoogle Scholar
  46. Stengard K (1994) Effect of toluene inhalation in extracellular striatal acetylcholine release studied with microdialysis. Pharmacol Toxicol 75:115–118PubMedCrossRefGoogle Scholar
  47. Stolerman IP, Samele C, Kamien JB, Mariathasan EA, Hague DS (1995) A bibliography of drug discrimination research, 1992–1994. Behav Pharmacol 6:643–668PubMedCrossRefGoogle Scholar
  48. Weiss B, Wood RW, Macys DA (1979) Behavioral toxicology of carbon disulfide and toluene. Environ Health Perspect 30:39–45PubMedCrossRefGoogle Scholar
  49. Wood RW, Colotla VA (1990) Biphasic changes in mouse motor activity during exposure to toluene. Fundam Appl Toxicol 14:6–14CrossRefPubMedGoogle Scholar
  50. Wood RW, Coleman JB, Schuler R, Cox C (1984) Anticonvulsant and antipunishment effects of toluene. J Pharmacol Exp Ther 230:407–412PubMedGoogle Scholar
  51. Yamawaki S, Segawa T, Sarai K (1982) Effects of acute and chronic toluene inhalation on behavior and (3H)-serotonin binding in the rat. Life Sci 30:1997–2002CrossRefPubMedGoogle Scholar
  52. Yavich L, Patkina N, Zvartau E (1994) Experimental estimation of addictive potential of a mixture of organic solvents. Eur Neuropsychopharmacol 4:111–118CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.Department of PsychologyWayne State UniversityDetroitUSA
  2. 2.Department of Obstetrics and GynecologyWayne State UniversityDetroitUSA

Personalised recommendations